IVERIC BIO INC's ticker is ISEE and the CUSIP is 46583P102. A total of 221 filers reported holding IVERIC BIO INC in Q3 2022. The put-call ratio across all filers is 0.34 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $6,655,600 | -27.7% | 280,000 | -34.9% | 0.73% | -23.9% |
| Q4 2022 | $9,206,300 | +5.4% | 430,000 | +17.8% | 0.96% | +5.1% |
| Q3 2022 | $8,731,000 | +263.0% | 365,000 | +46.0% | 0.91% | +234.8% |
| Q2 2022 | $2,405,000 | -45.0% | 250,000 | -3.8% | 0.27% | -36.8% |
| Q1 2022 | $4,376,000 | -23.9% | 260,000 | -25.7% | 0.43% | +12.8% |
| Q4 2021 | $5,754,000 | +1.2% | 350,000 | 0.0% | 0.38% | -4.0% |
| Q3 2021 | $5,684,000 | – | 350,000 | – | 0.40% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TCG Crossover Management, LLC | 5,141,118 | $110,071,336 | 19.43% |
| Deep Track Capital, LP | 7,878,119 | $168,670,528 | 7.08% |
| Soleus Capital Management, L.P. | 2,114,728 | $45,276,326 | 6.50% |
| MPM BioImpact LLC | 1,059,688 | $22,687,920 | 5.89% |
| Finepoint Capital LP | 707,600 | $15,150 | 4.90% |
| ACUTA CAPITAL PARTNERS, LLC | 360,500 | $7,718,305 | 4.75% |
| Octagon Capital Advisors LP | 1,278,000 | $27,361,980 | 4.26% |
| Artia Global Partners LP | 504,615 | $10,803,807 | 4.12% |
| Ghost Tree Capital, LLC | 450,000 | $9,635,000 | 4.11% |
| Redmile Group, LLC | 4,502,111 | $96,390,197 | 3.94% |